HER2 Advisory Board – Patients Needed
 

HER2 Advisory Board – Patients Needed

Genentech is seeking patients with early or metastatic breast cancer who have been on or are currently taking Herceptin (trastuzumab), Perjeta (pertuzumab) and/or Kadcyla (ado-trastuzumab emtansine or T-DM1). They will be hosting two advisory boards to include the patient perspective in the planning process for HER2 and equip patients with knowledge about HER2 therapies. Please reach out to their coordinating agency for additional information by emailing Jana Ross at jross@webershandwick.com.

Re: HER2 Advisory Board – Patients Needed
 

Hi!
I contacted Genentech...they're only signing up earl stage gals/guys right now. But they took my info and promised to get back to me if/when they're ready for stage IVs.
Denise